Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-011893-13Phase 4Active
Phase 4, open-label, single-arm trial of paroxetine, amitriptyline, clomipramine, imipramine, nortriptyline and 7 more in major depressive disorder (MDD), anxiety disorder and mental disorder, sponsored by Isala. Primary endpoint: Primary adherence assessment. Started Apr 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-011893-13.